Apolipoprotein E allele distribution in trisomy 13, 18, and 21 conceptuses in a Hungarian population

American Journal of Clinical Pathology

Volumn 113, Issue 4, 2000, Pages 535-538

  Nagy, Bálint ^a,d   Bán, Zoltán ^a   Tóth Pál, Ernö ^a   Papp, Csaba ^a   Fintor, LoU ^b,c   Papp, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d NONE   (Finland)

Author keywords

Apolipoprotein E; Fluorescent polymerase chain reaction; Trisomy 13; Trisomy 18; Trisomy 21

Indexed keywords

APOLIPOPROTEIN E; DNA FRAGMENT;

ALLELE; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DOWN SYNDROME; GENE FREQUENCY; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRISOMY 13; TRISOMY 18; TRISOMY 21;

EID: 0342699648     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/wxa4-ybrt-d2ag-ev67     Document Type: Article

References (24)

1. Cuckle HS, Wald NJ. Screening for Down's syndrome. In Liford R, ed. Prenatal Diagnosis and Prognosis. Vol 11. London, England: Butterworths;1990:67-92.
2. Adinolfi M, Crolla J. Nonisotopic in situ hybridization: clinical cytogenetics and gene applications. Adv Hum Genet. 1994;22:187-255.
3. Adinolfi M, Pertl B, Sherlock J. Rapid detection of aneuploidies by microsatellite and quantitative fluorescent polymerase chain reaction. Prenat Diagn. 1997;17:1299-1311.
4. Toth T, Findlay I, Papp C, et al. Prenatal detection of trisomy 21 and 18 from amniotic fluid by quantitative fluorescent polymerase chain reaction. J Med Genet. 1998;35:126-129.
5. Findlay I, Tóth T, Matthews P, et al. Rapid trisomy diagnosis (21, 18 and 13) using fluorescent PCR and short tandem repeats: application for prenatal diagnosis and preimplantation genetic diagnosis. J Assist Reprod Genet. 1998;15:266-275.
6. Boccini L, Nava S, Fogliani R, et al. Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Am J Obstet Gynecol. 1997;176:540-543.
7. Yla-Herttuala S, Luoma J, Nikkari T, et al. Down's syndrome and atherosclerosis. Atherosclerosis. 1989;76:269-272.
8. Brattstrom L, Englund E, Brun A. Does Down syndrome support homocysteine theory of atherosclerosis. Lancet. 1987;1:391-392.
9. Nagy B, Rigó J, Fintor L, et al. Apolipoprotein E alleles in women with severe pre-eclampsia. J Clin Pathol. 1998;51:324-325.
10. Nagy B, Karádi I, Fintor L, et al. Apolipoprotein E gene polymorphism frequencies in a sample of healthy Hungarians. Clin Chim Acta. 1999;282:147-150.
11. Wolstolme J, Crocker M, Jonasson J. A study of chromosomal aberrations in amniotic fluid cell cultures. Prenat Diagn. 1988;8:339-353.
12. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-548.
13. Clavel C, Durlach A, Durlach V, et al. Rapid and sensitive determination of human apolipoprotein E genotypes by miniaturized SDS-PAGE in non-insulin dependent diabetes mellitus. J Clin Pathol. 1995;48:295-299.
14. Avramopoulos D, Mikkelsen M, Vassilopoulos D, et al. Apolipoprotein allele distribution in parents of Down's syndrome children. Lancet. 1996;347:862-865.
15. Fisher JM, Harvey JF, Morton NE, et al. Trisomy 18: studies of parent and cell division of origin and the effect of aberrant recombination on non-disjunction. Am J Hum Genet. 1995;56:669-675.
16. Gaulden ME. Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutat Res. 1992;296:69-88.
17. Salo MK, Solakivi-Jaakkola T, Kivimaki T, et al. Plasma lipids and lipoproteins in Down's syndrome. Scand J Clin Lab Invest. 1979;39:485-490.
18. Hansen C, Bugge M, Brandt AC, et al. Apolipoprotein E alleles in mothers of trisomy 18 conceptuses. Clin Genet. 1998;53:321-322.
19. Hyman TB, West LH, Rebeck WG, et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci U S A. 1995;92:3583-3590.
20. Saunders MA, Schmader K, Breitner SCJ, et al. Apolipoprotein E ε4 allele distribution in late onset Alzheimer's disease and in other amyloid forming diseases. Lancet. 1994;343:979-980.
21. Pickering-Brown MS, Mann AMD, Bourke PJ, et al. Apolipoprotein E4 and Alzheimer disease pathology in Lewy body disease and in other beta-amyloid-forming disease [letter]. Lancet. 1994;343:1155.
22. Miyata M, Smith JD. Apolipoprotein E allele specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 1996;14:55-61.
23. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interaction of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A. 1994;91:11183-11186.
24. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90: 1977-1981.